Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride effectively treats male pattern baldness, improving hair growth and density.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Fadrozole and finasteride change gene expression related to sex hormones and thyroid hormones in frog larvae development.

SHBG may be a useful early indicator and treatment target for PCOS.

Finasteride helps reduce priapism in sickle cell anemia patients.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Finasteride may treat baldness but less effective for those with 5α-reductase deficiency.

Human hair contains diverse proteins, including keratins and histones, which could help assess hair health and aging.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Platelet lysate is a promising, cost-effective option for regenerative medicine with potential clinical applications.

Certain drugs that block specific enzymes can help treat prostate diseases.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Men with male-pattern baldness have more androgen receptors in their scalp's oil glands, which may contribute to hair loss.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Flutamide reduces hair growth better but has more side effects.

Eating healthy, exercising, and taking certain supplements can help manage Polycystic Ovary Syndrome symptoms.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

The research suggests that the global distribution of PCOS is likely due to historical human migration and that genes affecting PCOS may have different impacts on males and females.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Ketoconazole reduced hair growth and improved acne in women, but caused side effects needing careful monitoring.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.